Terumo Corporation
44-1, 2-chome
Hatagaya, Shibuya-ku
Tokyo
151-0072
Tel: 81-3-3374-8111
Fax: 81-3-3374-8399
Website: http://www.terumo.co.jp
66 articles about Terumo Corporation
-
MicroVention Celebrates 10-Year Anniversary and Legacy of SOFIA™ Aspiration Catheters; More than 500,000 Procedures Performed Worldwide Across 170 Countries
11/16/2023
MicroVention, Inc. is celebrating a decade of legacy innovation commemorating the anniversary of SOFIA™ and SOFIA™ Flow Plus Aspiration Catheters, with more than half a million worldwide procedures performed across 170 countries, and 30+ articles published globally since it was first introduced ten years ago.
-
Terumo Establishes Group-wide 'DE&I Philosophy' to Further Cultivate a Diverse, Equitable and Inclusive Culture
3/1/2022
Terumo Corporation announced that it has established a global "DE&I Philosophy" to further cultivate the culture of Diversity, Equity, and Inclusion at the Terumo Group.
-
Terumo Donates Additional USD 1 Million to Support the COVID-19 Solidarity Response Fund for WHO
5/14/2021
As the world joins together to fight the ongoing battle against the COVID-19 pandemic, Terumo Corporation has announced that the Terumo Group companies will collectively donate USD 1 million in cash to support the COVID-19 Solidarity Response Fund for the World Health Organization.
-
A Novel Drug-Device Combination Product Using Terumo's Automated Injection Device Completes Clinical Study in Japan
2/8/2021
Terumo Corporation announced the completion of a clinical study in Japan for a product using Terumo's automated injection device developed in collaboration with Kyowa Kirin Co., Ltd..
-
IceCure Inks Expanded Distribution Agreement with Terumo Corporation for Thailand
1/5/2021
Expanded Agreement Builds from the Success of its Current Joint Activities in Japan and Singapore, to Bring its Cryoablation Products to Benefit More Patients in Asia
-
Terumo Enters 100th Anniversary Year
1/5/2021
Terumo Corporation is celebrating its 100th anniversary this year - marking 100 years of 'Contributing to Society through Healthcare' on September 17, 2021.
-
Diabeloop SA. and Terumo Corporation enter into joint development agreement with exclusive distribution right for DBLG1® automated insulin delivery solution in Japanese market
11/16/2020
The French company Diabeloop, a pioneer in therapeutic AI, and Terumo Corporation, a global leader in medical technology, announced that they have signed an agreement for the joint development with exclusive distribution rights in Japan of an automated insulin delivery solution.
-
IceCure Expands Strategic Collaboration with Terumo: New Commercial Distribution Agreement Potentially Valued at over $7.0 Million
10/5/2020
Thailand, with a Population of 70 million People, Joins Other Significant Territories Japan and Singapore That will Benefit From IceCure's Cryoablation Products
-
Terumo Cardiovascular and CytoSorbents Collaborate to Commercialize CytoSorb® in Ten U.S. Hotspot States under Emergency Use Authorization for COVID-19
8/24/2020
Terumo Cardiovascular, a global leader in cardiovascular surgery technologies and subsidiary of Japan-based Terumo Corporation, and CytoSorbents Corporation, manufacturer of the CytoSorb® extracorporeal cytokine adsorber, announced an initial collaboration to exclusively sell CytoSorb to hospitals in ten U.S.
-
Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field
7/15/2020
Terumo Corporation announced it has completed the acquisition of Quirem Medical B.V., a Netherlands-based healthcare startup specializing in the development of next-generation microspheres for Selective Internal Radiation Therapy, a treatment for liver tumors.
-
Fibralign Announces Strategic Partnership With Terumo
6/2/2020
Fibralign Corp., a Stanford spin-out developer of therapeutic biomedical devices, has announced that it has executed a long term distributor agreement with Terumo Corporation to market and distribute the BioBridge® Collagen Matrix in Japan for treating and preventing secondary lymphedema.
-
Orchestra BioMed™ Announces Global Strategic Partnership with Terumo Corporation for Development and Commercialization of Virtue® Sirolimus-Eluting Balloon
6/13/2019
Virtue® SEB is expected to become a flagship therapeutic product for Terumo and will strengthen its broad US and global portfolio of interventional solutions
-
Terumo Enhances Coronary Interventional Product Portfolio By Securing Exclusive Global Rights to Orchestra BioMed's Virtue® Sirolimus-Eluting Balloon (SEB) through Global Strategic Partnership
6/13/2019
First and only non-coated drug-eluting angioplasty balloon that delivers a proprietary bioabsorbable, sustained-release formulation of sirolimus
-
MicroVention Announces Positive Safety And Effectiveness Results In Web-It Pivotal Trial Published In Journal Of NeuroInterventional Surgery
4/18/2019
The WEB-IT pivotal trial highlights positive clinical outcomes with the WEB® Aneurysm Embolization System, the only intrasaccular flow disruptor approved in the United States.
-
Xenex Expands Relationship with Terumo; LightStrike Germ-Zapping Robots Now Available in Singapore
4/18/2018
Xenex Disinfection Services announced it has expanded its relationship with Terumo Corporation.
-
Medeon Entering Asset Purchase Agreement with Terumo for its Large Bore Vascular Closure System
3/5/2018
Medeon Biodesign, Inc. is pleased to announce today that it entered into a definitive asset purchase agreement with Tokyo-based Terumo Corporation for its large bore vascular closure system.
-
MicroVention And Terumo Announce Data From Multicenter GREAT Study
3/7/2017
-
Terumo Chooses Xenex Lightstrike Germ-Zapping Robots To Disinfect Healthcare Facilities & Improve Patient Safety In Japan
1/5/2017
-
St. Jude Medical And Abbott to Sell Some Medical Devices to Terumo in $1.12 Billion Deal
10/19/2016
-
Rumor Has Terumo Eyeing Abbott's Cardio Biz
9/30/2016